Telmisartan decreases microalbuminuria in patients with type 2 diabetes mellitus following coronary artery bypass grafting


Creative Commons License

Furat C., DOĞAN R., Ilhan G., Bayar E., Ozpak B., Kara H., ...Daha Fazla

CARDIOVASCULAR JOURNAL OF AFRICA, cilt.28, sa.3, ss.191-195, 2017 (SCI-Expanded, Scopus)

Özet

Objective: This prospective study aimed to investigate the effects of the selective angiotensin receptor antagonist, telmisartan, on microalbuminuria after coronary artery bypass surgery in patients with diabetes mellitus.